Skip to main content
. 2019 Jul 9;20(4):e35. doi: 10.4142/jvs.2019.20.e35

Table 4. Lung and lymph node score in different treatment groups.

Groups Lung (%) Lymph node
rAd 17.4 ± 1.1 3.75 ± 0.25
rAd-Cap 8.4 ± 0.74*,† 2.33 ± 0.33
rAd-Cap-InvC 1.6 ± 0.16* 0.75 ± 0.25*
ZJ/C-strain vaccine 0.87 ± 0.2* 0*
PBS 18.5 ± 0.52 3.67 ± 0.33

Cap, protein capsid; InvC, C-terminal domain of Yersinia pseudotuberculosis invasin; PBS, phosphate-buffered saline.

*,†The mean lesion scores with different superscripts are significantly different from each other (p < 0.05).